Human Molecular Genetics Advance Access originally published online on July 15, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2003, Vol. 12, No. 17 2153-2165
DOI: 10.1093/hmg/ddg231
© 2003 Oxford University Press
Monosomy 1p36 breakpoint junctions suggest pre-meiotic breakagefusionbridge cycles are involved in generating terminal deletions
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA and 2Health Research and Education Center, Washington State University, Spokane, WA 99210, USA
Received April 24, 2003; Accepted July 5, 2003
Terminal deletions of 1p36 result in a mental retardation syndrome that is presumably caused by haploinsufficiency of a number of genes. Although monosomy 1p36 is the most commonly observed terminal deletion syndrome in humans, the molecular mechanism(s) that generates and stabilizes terminal deletions of 1p36 is not completely understood. Our previous molecular analysis of a large cohort of monosomy 1p36 subjects demonstrated that deletion sizes vary widely from
1 Mb to >10.5 Mb in the most distal portion of 1p36 with no single common breakpoint. In this report, we have identified the precise breakpoint junctions in three subjects with apparently pure terminal deletions of 1p36 ranging from 2.5 to 4.25 Mb. These junctions revealed one deletion to be stabilized by telomeric repeat sequences and two to have terminal deletions associated with cryptic interrupted inverted duplications at the ends of the chromosomes. These interrupted inverted duplication/deletion breakpoints are reminiscent of those seen in tumor cell lines that have undergone breakagefusionbridge (BFB) cycles leading to gene amplification. We propose a pre-meiotic model for the formation of these deletions in which a terminally deleted chromosome is generated in the germ line and passes through at least one BFB cycle to produce gametes with terminal deletions associated with interrupted inverted duplications. These data suggest that, on a molecular level, seemingly pure terminal deletions visualized cytogenetically may be more complex, and BFB cycles may play an important role in generating terminal deletions associated with genetic disease in humans.
* To whom correspondence should be addressed at: Washington State University Spokane, Health Research and Education Center, Box 1495, Spokane, WA 99210-1495, USA. Tel: +1 5093686710; Fax: +1 5093587627; Email: lshaffer{at}wsu.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E Rossi, M Riegel, J Messa, S Gimelli, P Maraschio, R Ciccone, M Stroppi, P Riva, C S Perrotta, T Mattina, et al. Duplications in addition to terminal deletions are present in a proportion of ring chromosomes: clues to the mechanisms of formation J. Med. Genet., March 1, 2008; 45(3): 147 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
M C Bonaglia, R Giorda, E Mani, G Aceti, B-M Anderlid, A Baroncini, T Pramparo, and O Zuffardi Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome J. Med. Genet., October 1, 2006; 43(10): 822 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Ciccone, T Mattina, R Giorda, M C Bonaglia, M Rocchi, T Pramparo, and O Zuffardi Inversion polymorphisms and non-contiguous terminal deletions: the cause and the (unpredicted) effect of our genome architecture. J. Med. Genet., May 1, 2006; 43(5): e19 - e19. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Shaffer and B. A. Bejjani A cytogeneticist's perspective on genomic microarrays Hum. Reprod. Update, May 1, 2004; 10(3): 221 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Shaw and J. R. Lupski Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease Hum. Mol. Genet., April 1, 2004; 13(90001): R57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yu, B. C. Ballif, C. D. Kashork, H. A. Heilstedt, L. A. Howard, W.-W. Cai, L. D. White, W. Liu, A. L. Beaudet, B. A. Bejjani, et al. Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions Hum. Mol. Genet., September 1, 2003; 12(17): 2145 - 2152. [Abstract] [Full Text] [PDF] |
||||


